Every Cure, a nonprofit organization focused on drug repurposing, has secured $76.0 million in funding. This significant capital infusion will accelerate the organization's mission to identify and advance existing medicines for new therapeutic uses, addressing a critical need in healthcare by leveraging the full potential of approved drugs.
The organization is dedicated to unlocking the full potential of every existing medicine to treat every disease possible. Every Cure operates on the principle that repurposing existing drugs offers the fastest and most efficient pathway to treat diseases, providing a high return on investment for saving lives. Despite this potential, systemic barriers often impede the repurposing process, leaving many patients without fully utilized treatment options. Every Cure aims to overcome these challenges by systematically identifying and advancing promising repurposing opportunities.
Every Cure is developing a comprehensive, open-source data engine designed to generate predictive efficacy scores for all 3,000 drugs against all 12,000 diseases. This revolutionary approach integrates proprietary and public data, optimizes AI ranking algorithms, and validates the most promising drug-disease matches. In partnership with academia, industry, and government, the organization performs trials and works to ensure patient access to effective therapies. The newly raised capital will be instrumental in further developing this data engine, expanding research initiatives, and advancing promising drug candidates through clinical validation. This investment underscores a commitment to rapidly bringing new treatment options to patients and scaling Every Cure's impactful work in drug repurposing.
.png&w=3840&q=75)
